Study objectives: The influences of different smoking categories on the prevalence of respiratory symptoms, asthma, and chronic bronchitis have been examined in the most northern province of Sweden, Norrbotten, and in Lapland, Finland. The two areas have similar geographic and demographic conditions. Methods and study population: The study is a part of the FinEsS studies, which are epidemiologic respiratory surveys in progress in Sweden, Finland, and Estonia. A random sample of 20-to 69-years-olds were invited to answer a postal questionnaire about respiratory symptoms, smoking habits, and occupation. In Norrbotten, 8,333 subjects were invited and 7,104 responded (85%). In Lapland, 8,005 were invited and 6,633 responded (83%). Results: The participation by age and sex was similar in both countries. The prevalence of smokers in Lapland was 32% vs 26% in Norrbotten. Significantly more women than men in Norrbotten were smokers, while the opposite was true for Lapland. Sputum production was the most prevalent symptom in both areas, 25% in Lapland vs 19% in Norrbotten. The prevalence of chronic productive cough was 11% in Lapland and 7% in Norrbotten. Bronchitic symptoms were more prevalent in Lapland among both smokers and nonsmokers. A positive family history of chronic obstructive airway disease together with increased number of consumed cigarettes showed an additive effect for both chronic productive cough and wheezing. The odds ratio (OR) for wheezing during the last 12 months was 3.8 for subjects without a family history of obstructive airway disease who consumed > 14 cigarettes per day compared with nonsmokers, but if the subjects had a family history of obstructive airway disease, the risk for wheezing increased to OR 8.4. Conclusion: Bronchitic symptoms were more common in Finland. The difference remained also after correction for demographic variables including smoking habits, age and socioeconomic group, and family history of obstructive airway disease. Identical methods, sample composition, and the high participation rate contribute to the validity of the results. Air pollution, including environmental tobacco smoke, may contribute to the difference. To explain the difference, further analysis and investigations of social and environmental factors as well as genetic factors are needed.
S
moking is a major health problem. Tobacco use is by far the most important risk factor for most respiratory symptoms and chronic bronchitis. [1] [2] [3] [4] [5] Active smoking has been identified as the most important single factor leading to the development of COPD. [6] [7] [8] [9] Furthermore, smoking is a major cause of disability and death. 6, 7, 10 In many developed countries, the proportion of smokers in the population has decreased during last decades. 11 However, smoking is a common habit among young adults in many countries. That is true also in the Nordic countries, where many preventive efforts, such as legislation, have been made in order to restrict smoking in public places and prevent the start of smoking. 12, 13 Epidemiologic studies from the 1960s to 1980s have shown a considerably higher prevalence of chronic bronchitis in Finland (8 to 17%) 3,14 compared to Sweden (1.4 to 4%). 4, 15, 16 Chronic bronchitis was strongly related to smoking in these studies, which explained considerable gender differences in prevalence of chronic bronchitis. 3, 15, 16 The differences in prevalence between the countries may be caused by differences in smoking habits. However, in these studies, different methods and often different criteria for defining disease were used. The first of the Obstructive Lung Disease in Northern Sweden (OLIN) studies yielded a prevalence for chronic bronchitis of 10% by using structured interview in 1986 -1987, 17 indicating that the difference in prevalence between the countries might have been overestimated.
The aim of this survey was to study the influence of different smoking categories on prevalence of respiratory symptoms and chronic bronchitis in Northern Sweden and Northern Finland. A further aim was to investigate whether or not the differences in smoking habits and prevalence of the symptoms and diseases between Sweden and Finland still existed. The possibility to compare the effects of smoking in Northern Finland and Northern Sweden by the current study was good, as the areas are similar with respect to climatic aspects, population density, degree of urbanization, socioeconomic development, type of industry, and social life. In addition, identical methods, criteria, and sample composition were used in the two surveys.
Materials and Methods

Study Areas
The study area in Northern Sweden was Norrbotten, the northernmost province of Sweden, with an area of 105,886 square kilometers, or 24% of the area of Sweden (Fig 1) . The average yearly temperature is close to 0°C. The winters last for 6 months, and the summers last for only 2 to 3 months. There were 266,011 inhabitants in December 1995, which corresponded to Ͻ 3% of the population of Sweden. The main industries include steel, paper, and paper pulp industries, iron mines, forestry, as well as commerce, trade, and administration. Only 3% are employed by agriculture, the importance of which has decreased during the last decades.
Finnish Lapland, the northernmost province of Finland, had in December 31, 1995, a population of 201,411 people, 4% of the population of Finland. The area of Lapland is 93,057 square kilometers (31% of the area of Finland), yielding a very low population density similar to Swedish Norrbotten. The climate and the main industries are similar in Northern Sweden, with the exception of agriculture, in which 7% of the adult population of Northern Finland is employed.
Study Population
A postal questionnaire on respiratory symptoms and diseases, smoking habits, and occupation was sent to randomly selected subjects aged 20 to 69 years in Norrbotten and Lapland. The sample of subjects was obtained from the population registers in the two countries, and corresponded to the general population with respect to age and sex in the age range of 20 to 69 years. The size of the sample in Norrbotten was 8,333 subjects (4,351 men); in Lapland, it was 8,005 subjects (4,067 men). After two reminders in Norrbotten and three in Lapland, the questionnaires were completed by 7,104 subjects (85%) in Norrbotten, and by 6,633 subjects (83%) in Lapland.
Questionnaire
The questionnaire was developed from the OLIN studies questionnaire, 4 which had been developed from a Swedish questionnaire 16 based on the British Medical Research Council questionnaire, 18 with influences from the United States Tucson questionnaire, 19 and it had been used in several Nordic epidemiologic studies. 4,17,20 -22 In addition to the OLIN studies questionnaire, the version used in the current study included two questions from the IUATLD questionnaire, 23 questions that had been used in the European Community Respiratory Health Survey. 24 The questionnaire included questions about asthma, chronic bronchitis, allergic rhinitis, and various respiratory symptoms, such as cough, sputum production, wheeze, chest tightness, and attacks of shortness of breath. Questions about use of asthma medicines, smoking habits, family history of obstructive airway disease, and socioeconomic group based on occupation were included.
Definitions
The following definitions for symptoms, conditions, and smoking habits were used, based on the responses to the following questions:
Physician-Diagnosed Chronic Bronchitis: "Have you been diagnosed as having chronic bronchitis or emphysema by a physician?" 4 Sputum Production: "Do you usually have phlegm when coughing, or do you have phlegm in your chest that is difficult to bring up?" 4 Chronic Productive Cough: "Do you bring up phlegm when coughing on most days during periods of at least 3 months during at least 2 successive years?" 4, 18, 25 Wheezing During the Preceding 12 Months: "Have you at any time during the last 12 months had wheezing or whistling in your chest?" 23, 24 Dyspnea Grade 2: "Do you get short of breath or have to walk more slowly when you walk with other people of your own age on level ground at normal pace?" 4, 18 Smoking Habits: Those who had stopped smoking at least 12 months before the study were classified as ex-smokers. For current smokers, a question was included with three alternatives about the number of cigarettes consumed: Ͻ 5 cigarettes per day, 5 to 14 cigarettes per day, and Ͼ 14 cigarettes per day.
Nonresponders Study
A study on nonresponders was performed in both areas. In Norrbotten, a total of 1,229 subjects (712 men) did not participate in the postal survey, and a random sample of 200
subjects was selected for a study of nonresponders. Nonparticipants in Lapland included 1,372 subjects (848 men), and 384 subjects were selected to the nonresponders study. The subjects were contacted and interviewed over the telephone about the questions in the mailed questionnaire and, furthermore, the reason why they had not responded to the postal questionnaire.
The nonresponders were often young men, and they were more often smokers than the responders. The main reason for nonresponse was forgetfulness. The prevalence of symptoms among the nonresponders was not significantly different from the participants in the survey.
Analysis
Statistical analyses were performed by using the Statistical Package for the Social Sciences (SPSS; Chicago, IL), at the National Institute for Working Life in Umeå, Sweden. The 2 test and one-way analysis of variance were used for categorical comparisons. Prevalence rates were also standardized for age and smoking, both separately and simultaneously, using the MantelHaenszel test. The simultaneous effects of different independent variables on respiratory symptoms were calculated by using multiple logistic regression analysis. The independent variables used in the analyses were age, sex, family history of obstructive airway diseases (chronic bronchitis, emphysema, or asthma), smoking habits, and country.
Results
Participation
The participation by age and sex was similar in the two areas. Of women, 87% responded in both areas, while the response rates among men were 83% in Norrbotten and 79% in Lapland. The highest response rate (90%) in both areas was among women Ͼ 50 years old, and the lowest in Norrbotten among men aged 20 to 29 years (78%), and in Lapland among men aged 40 to 49 years (76%).
Smoking Habits
The proportion of current smokers was 32% in Lapland vs 26% in Norrbotten (p Ͻ 0.001; Table 1 ). Significantly more women than men were smokers in Norrbotten (29% vs 24%), while the opposite was true for Lapland (28% vs 37%). The difference in smoking habits between men and women in Lapland was similar in all age cohorts. In Norrbotten, the difference was most pronounced in young adults, while no difference was found in the age cohort of 60 to 69 years. Smoking was most common in Lapland among subjects aged 20 to 29 years, 47% in men and 40% in women (p ϭ 0.02). In Norrbotten, the corresponding figures were 16% in men and 26% in women (p Ͻ 0.001), while current smoking was most common in subjects aged 40 to 59 years (approximately 30%). The prevalence for those who smoked Ͼ 14 cigarettes per day was 12% in Lapland vs 7% in Norrbotten (p Ͻ 0.001).
Prevalence of Respiratory Symptoms and Diseases
The most common respiratory symptom in both countries was sputum production, 19% in Norrbotten vs 25% in Lapland. It was equally common in men and women in both areas, and the prevalence was highest in the oldest age cohort followed by the youngest age cohort (Table 2) . Sputum production was reported by 33% of smokers in Lapland vs 26% in Norrbotten (Table 3) . Of women in Lapland who smoked Ͼ 14 cigarettes per day, sputum production was reported by Ͼ 50%. The prevalence among smokers in the youngest age cohort in Lapland was 34% in both men and women, vs 28% in men and 29% in women in Norrbotten.
Chronic productive cough increased by age, and was reported by 11% in Lapland vs 7% in Norrbotten ( Table 2 ). The influence of smoking on chronic productive cough was most pronounced among women. Of women in Lapland who smoked Ͼ 14 cigarettes per day, 25% reported chronic productive cough vs 16% in Norrbotten (Fig 2) . The relationship between smoking and wheezing during the preceding 12 months was similar; among women in Norrbotten, the prevalence in the smoking category Ͼ 14 cigarettes per day was 39% vs 36% in Lapland (Fig 2) , while the prevalence in nonsmoking women was 15% in Norrbotten vs 14% in Lapland (Table 3) .
Physician-diagnosed chronic bronchitis was reported by 3.1% in Lapland vs 3.8% in Norrbotten, while bronchitic symptoms were all more common in Lapland (Table 2) .
Multivariate Relationships
Risks (odds ratio [OR]) for respiratory symptoms were estimated by multiple logistic regression analysis (Table 4 ). Significant risk factors for chronic productive cough were family history of obstructive airway disease (OR, 2.2), age Ͼ 40 years, and current smoking. Smoking Ͻ 5 cigarettes per day was not associated with an increased risk for chronic productive cough, while smoking Ͼ 14 cigarettes per day yielded an OR of 2.9. The risk factor pattern for sputum production was similar to that for chronic productive cough. For wheezing during the last 12 months, exsmoking was associated with an increased risk (OR,
No gender difference was found for any of the analyzed symptoms after correction for age, smoking habits, and family history of obstructive airway disease, except for dyspnea; for dyspnea, female sex was associated with an increased risk. Manual work in industry was associated with a significantly increased risk for sputum production, chronic productive cough, dyspnea, and physician-diagnosed chronic bronchitis, with the ORs varying from 1.23 to 1.76 (Table 4) .
Country occurred as an independent determinant for bronchitic symptoms and dyspnea. Living in Finland was associated with a greater risk for chronic productive cough (OR, 1.5), sputum production (OR, 1.4), and dyspnea (OR, 2.3). When the multiple logistic regression analyses were performed separately for each country, the risk-factor pattern remained similar. For instance, smoking Ͼ 14 cigarettes per day was associated with an increased risk for wheezing (OR, 3.6) in both countries. In addition, socioeconomic group influenced the symptoms similarly in both countries.
The prevalence rates of symptoms were also standardized for smoking and age by using the MantelHaenszel test. When the results were standardized for smoking habits, the differences in prevalence of both sputum production and chronic productive cough between the two areas decreased with approximately one percentage unit. The age composition of the samples from the two was similar, explaining why further standardization for age did not influence the results.
As family history of obstructive airways disease and the number of cigarettes were risk factors of similar magnitude for both chronic productive cough and wheezing during the last 12 months, the combined risks of the two factors were calculated (Fig 3) . Among subjects who did not have a family history of obstructive airway disease, smoking Ͼ 14 cigarettes per day yielded an OR of 2.7. When having a family history of obstructive airway disease, the risk was doubled among nonsmokers (OR 2.0); for smokers of Ͼ 14 cigarettes per day, the OR was 6.9. The influence of smoking and family history of obstructive airways disease on wheezing during the last 12 months was even greater, compared to the influence on chronic productive cough. Among subjects without a family history of obstructive airway disease, the OR was 3.8 when Ͼ 14 cigarettes per day were consumed. If the smokers had a family history of obstructive airway disease, the OR was 8.4. The results indicated a strong additive effect of family history of obstructive airway disease and smoking for chronic productive cough, as well as for wheezing during the last 12 months (Fig 3) .
Discussion
This study compares the prevalence of respiratory symptoms and conditions and their relationship to smoking habits and other risk factors in Lapland in Northern Finland and Norrbotten in Northern Sweden. The study is a part of comparative epidemiologic studies in progress in Finland, Estonia, and Sweden, the FinEsS-studies. The effects of smoking on respiratory symptoms and diseases comprise an important part of these studies. Young adults have been studied in the European Community Respiratory Health Survey. 24 There is a lack of recent data about middle-aged and elderly persons. This study includes people also in the ages of 45 to 69 years, in that smoking-related conditions and chronic bronchitis become even more prevalent.
The proportion of smokers was greater in Lapland than in Norrbotten, particularly among young adults. More men than women were smokers in Lapland, while the opposite was true for Norrbotten. When compared with a number of older studies, 3, 4, 20, 26 our study indicated that the proportion of smokers has decreased among men but not among women in Finland, and in both men and women in Sweden.
The most common respiratory symptom, sputum production, was reported by Ͼ 50% of women in Lapland who smoked Ͼ 14 cigarettes per day. Wheezing during last 12 months was equally common in the two areas, and was also strongly smoking dependent, a known association. 4, 27 Most symptoms were equally prevalent in the sexes and only slightly age dependent. These results contrast to previously performed Swedish, Finnish, and other Nordic studies, showing most respiratory symptoms to be strongly age dependent, 3, 4, 15, 26, 28 and more prevalent in men, 3, 16, 17, 26 probably because of gender differences in smoking habits.
The prevalence of physician-diagnosed chronic bronchitis was 3.1% in Lapland and 3.8% in Norrbotten, and was similar in both areas for in men and women. The results, together with results from a study 29 from Southern Finland, indicate a decrease in prevalence of chronic bronchitis, particularly among men, in Finland. 3 No change since 1986 was shown for Norrbotten. 4 In opposition to the prevalence of physician-diagnosed chronic bronchitis, the prevalence of chronic productive cough was higher in Lapland (11%) than in Norrbotten (7%), suggesting a difference between the two areas in classification of disease, or diagnostic praxis, as the healthcare systems in the two areas are similar. Another explanation could be that people in Norrbotten are more prone to seek health care for their symptoms.
The association between smoking and chronic productive cough is well known. 1, 3, 4, 28 We found a linear increase in prevalence of chronic productive cough with increasing number of consumed ciga- rettes. The condition became more common with increasing age, even among nonsmokers, suggesting other factors in addition to smoking to be of importance for developing the condition. Farming 30 and airborne occupational exposures are possible factors. [31] [32] [33] [34] These factors, as well as urban living in large cities, 35 are not present in Lapland and Norrbotten. The increase by age may, in part, be explained by the fact that the effectiveness of the mucociliary clearance decreases with increasing age. 36 As previously, bronchitic symptoms were still more prevalent in Finland. This was true also in nonsmokers, particularly among women, suggesting that factors other than smoking contribute to the development of these symptoms. Socioeconomic group as risk for the symptoms did not explain the differences between the countries, and the degree of urbanization is similar in both areas. Although in both Sweden and Finland air pollution has decreased, differences still exist that may contribute to the differences in prevalence of bronchitic symptoms between the two countries. Air pollution control started in Finland in 1982, 37 and local authorities promote air control and monitoring according to local circumstances. Indoor exposures from gasoline and unprocessed solid fuels, such as coal, wood, and peat, are known risk factors for respiratory symptoms. 38, 39 For the heating of houses in these coldclimate areas, unprocessed solid fuels are used in approximately 40% in Lapland vs 20% in Norrbotten, according to the Ministry of Environment in Finland. Particularly, more peat is used for energy production in Finland than in Sweden.
Sulfur emissions are still greater in Finland than in Sweden. Finland receives more sulfur emissions from Russia than from any other source. The biggest point sources of Russian sulfur emissions are located close to the border to Finland, particularly in the Murmansk region, the Karelian Republic, and St. Petersburg. 40 Finland and Russia signed an agreement in 1992 on cooperation toward reducing sulfur emissions. However, economic problems in Russia have delayed implementation. 40 An important source of indoor air pollution is environmental tobacco smoke (ETS). 41 In young adults, the incidence of respiratory symptoms was higher among subjects exposed to ETS, compared to those not exposed. 42 The greater proportion of smokers in Finland results also in a greater exposure of ETS. Preventive actions against smoking started in Sweden in 1960, with legislation on health warnings and an advertising ban. In Finland, a special law on tobacco-use health warnings was introduced in 1977, and preventive activities in the Finnish society began later.
Genetic factors may also contribute to the differences, as the Finnish and the Swedish people have different genetic origins. The multivariate analyses pointed out family history of obstructive airway disease to be an important risk factor for most symptoms and for chronic bronchitis. For both chronic productive cough and for wheezing, a strong additive effect was seen between smoking and family history of obstructive airway disease.
Similar geographic and demographic conditions in the two areas, together with the same methodology, large sample sizes, and the high participation rate (in both areas approximately 85%), contribute to the validity of the results. Risks (ORs) with 95% confidence intervals for chronic productive cough and wheezing during the last 12 months, respectively, in relation to a family history (FH) of obstructive airway disease and different smoking categories calculated by multiple logistic regression analysis after adjustment for age, gender, socioeconomic group, and country. n-s ϭ nonsmokers; ex-s ϭ ex-smokers; see Figure 2 legend for expansion of abbreviation.
In conclusion, bronchitic symptoms are still common in Northern Sweden and Northern Finland, and prevalence is strongly related to the number of consumed cigarettes per day. Country occurred as an independent determinant for bronchitic symptoms, and living in Finland was associated with a greater risk, which may in part be explained by air pollution including ETS.
